Clinical Trial: Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin

U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07093476) titled 'Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin' on June 30.

Brief Summary: Phase 3 study to assess the Efficacy and Safety of CT-L02-301 in Type 2 Diabetes Patients with Insufficient Glycemic Control with Metformin and Alogliptin Combination Therapy.

Study Start Date: July 18

Study Type: INTERVENTIONAL

Condition: T2DM Diabete Type 2 DM

Intervention: DRUG: Metformin

tablets, QD, oral administration

DRUG: Alogliptin

tablets, QD, oral administration

DRUG: empagliflozin

tablets, QD, oral administration

Recruitment Status: ENROLLING_BY_INVI...